Health Law & Business News

CVS Must Face Antitrust Suit Over Compliance Software

April 4, 2019, 6:05 PM

CVS Pharmacy Inc. can’t dodge an antitrust lawsuit accusing it of requiring hospitals it deals with to use a subsidiary’s software for tracking drug inventory and managing regulatory compliance.

Sentry Data Systems Inc., which makes competing software, can proceed with its claims that CVS violated Section 1 of the Sherman Act by tying its contract pharmacy services to software developed by Wellpartner Inc., a Florida federal judge ruled April 3.

The software products sold by Sentry and Wellpartner, which CVS acquired in 2017, help hospitals comply with the federal 340B program. The program created a “self-auditing” regime requiring close monitoring...

To read the full article log in. To learn more about a subscription click here.